1. Home
  2. PRAX vs APPF Comparison

PRAX vs APPF Comparison

Compare PRAX & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$305.51

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo AppFolio Inc.

APPF

AppFolio Inc.

HOLD

Current Price

$191.69

Market Cap

6.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
APPF
Founded
2015
2006
Country
United States
United States
Employees
N/A
1702
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.4B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
PRAX
APPF
Price
$305.51
$191.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
9
Target Price
$572.13
$286.78
AVG Volume (30 Days)
329.6K
367.7K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.36
Revenue
N/A
$950,822,000.00
Revenue This Year
N/A
$19.69
Revenue Next Year
$7,758.26
$16.70
P/E Ratio
N/A
$76.35
Revenue Growth
N/A
19.72
52 Week Low
$37.25
$142.56
52 Week High
$366.52
$323.34

Technical Indicators

Market Signals
Indicator
PRAX
APPF
Relative Strength Index (RSI) 46.51 63.01
Support Level $284.87 $157.79
Resistance Level $331.21 $240.32
Average True Range (ATR) 16.88 8.56
MACD -2.16 1.16
Stochastic Oscillator 34.34 99.31

Price Performance

Historical Comparison
PRAX
APPF

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

Share on Social Networks: